UK News

UK News

The latest from the UK pharmacuetical industry

NICE Recommends More Digital Mental Health Therapies For NHS UseNICE Recommends More Digital Mental Health Therapies For NHS Use
NICE Recommends More Digital Mental Health Therapies For NHS Use

NICE has recommended eight new digital therapies to be used by the NHS for the treatment of mental health disorders

Mar 6, 2023 UK News
Eli Lilly And AbbVie Leave UK VPAS; Blow To UK Pharma IndustryEli Lilly And AbbVie Leave UK VPAS; Blow To UK Pharma Industry
Eli Lilly And AbbVie Leave UK VPAS; Blow To UK Pharma Industry

Eli Lilly and AbbVie both announce that they will leave VPAS, causing concern that NHS patients may not receive breakthrough drug treatments

Mar 6, 2023 UK News
Merck’s London Research Hub To Begin Construction In April 2023Merck’s London Research Hub To Begin Construction In April 2023
Merck’s London Research Hub To Begin Construction In April 2023

Merck has been planning a $1.3bn research hub in london for the last six years, but this will finally begin construction in April

Mar 6, 2023 UK News
Cambridge’s Experimental Cancer Medicine Centre To Receive FundingCambridge’s Experimental Cancer Medicine Centre To Receive Funding
Cambridge’s Experimental Cancer Medicine Centre To Receive Funding

The ECMC in Cambridge is one of a handful of organisations to receive a share of £47.5 funding over the next five years

Mar 6, 2023 UK News
NHS To Offer Artificial Pancreas To Type 1 Diabetes PatientsNHS To Offer Artificial Pancreas To Type 1 Diabetes Patients
NHS To Offer Artificial Pancreas To Type 1 Diabetes Patients

The NHS will soon begin offering artificial pancreas to type 1 diabetes patients to help them manage their condition more effectively

Mar 6, 2023 UK News
Scottish Biotech Aims To Cure Common ColdScottish Biotech Aims To Cure Common Cold
Scottish Biotech Aims To Cure Common Cold

ScotBio has announced "promising initial results" from its attempt to extract a cure for the common cold from algae

Mar 6, 2023 UK News
UCL To Begin New Trial To Assess Cough Medicine’s Impact On Parkinson’s DiseaseUCL To Begin New Trial To Assess Cough Medicine’s Impact On Parkinson’s Disease
UCL To Begin New Trial To Assess Cough Medicine’s Impact On Parkinson’s Disease

Researchers at UCL have begun looking into the impacts of ambroxol as a treatment for Parkinson's disease

Mar 6, 2023 UK News
Government “Adamantly Refused” To Engage In A “proper Discussion” On Pay Ahead Of Ambulance StrikesGovernment “Adamantly Refused” To Engage In A “proper Discussion” On Pay Ahead Of Ambulance Strikes
Government “Adamantly Refused” To Engage In A “proper Discussion” On Pay Ahead Of Ambulance Strikes

Unison general secretary Christina McAnea said that the ongoing ambulance strikes will continue to go ahead without a “very firm commitment” on pay, as the Government has “adamantly refused” to engage in a “proper discussion” about pay rises.

Feb 1, 2023 UK News
Gsk Chooses London’s West End For New HeadquartersGsk Chooses London’s West End For New Headquarters
Gsk Chooses London’s West End For New Headquarters

GlaxoSmithKline has chosen to establish its new headquarters in London’s West End, on the corner of New Oxford Street and Earnshaw Street in the Capital’s centre. The new hub is expected to open in 2024.

Feb 1, 2023 UK News
Lumiradx Receives $14m In Funding For Point-of-care Tb TestLumiradx Receives $14m In Funding For Point-of-care Tb Test
Lumiradx Receives $14m In Funding For Point-of-care Tb Test

UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support the ongoing development of its point-of-care molecular tuberculosis (TB) test system.

Feb 1, 2023 UK News
Lilly & Sosei Enter MultiTarget Collaboration & Licence Agreement For Diabetes & Metabolic DiseasesLilly & Sosei Enter MultiTarget Collaboration & Licence Agreement For Diabetes & Metabolic Diseases
Lilly & Sosei Enter MultiTarget Collaboration & Licence Agreement For Diabetes & Metabolic Diseases

Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and commercialise small molecules that modulate novel G protein-coupled receptor (GPCR) targets associated with diabetes and metabolic diseases.

Feb 1, 2023 UK News
Biontech And UK Government Announce Strategic Partnership To Provide mRNA Cancer ImmunotherapiesBiontech And UK Government Announce Strategic Partnership To Provide mRNA Cancer Immunotherapies
Biontech And UK Government Announce Strategic Partnership To Provide mRNA Cancer Immunotherapies

German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU), which will accelerate clinical trials of personalised mRNA immunotherapies. It is hoped this acceleration will lead to up to 10,000 patients receiving such therapies by the end of 2030.

Feb 1, 2023 UK News